Opaleye Management, a 10% owner, adds $2.79M in Sol-Gel shares
SLGL has more than doubled off its 52-week low of $21.1 on elevated volume (2.3× avg).
Summary
10% owner Opaleye Management bought $2.79M of Sol-Gel shares, increasing its position to 525,217 shares.
Key Events · Ownership and Investor Activity · SLGL
-
10% Owner Adds $2.79M Position
Opaleye Management bought 40,330 shares for $2,790,326 across five transactions on August 28 and 31, at prices ranging from $68.23 to $71.40.
-
Stake Rises to 525,217 Shares
Post-transaction holdings reached 525,217 shares, up from 484,887 shares before the purchases.
-
Correction of Erroneous Sale
10,000 of the shares were purchased to correct an erroneous sale on August 28, 2026; the remaining 30,113 shares were new acquisitions.
-
Follows Q2 Results and Phase 3 Update
The buying comes after Sol-Gel reported Q2 revenue of $0.6M and a net loss of $3.7M on August 20, and confirmed Phase 3 SGT-610 top-line data is expected in late November.
Analysis · SLGL · Life Sciences
Opaleye Management, a 10% owner, bought $2.79 million of Sol-Gel stock across five transactions on August 28 and 31, lifting its stake to 525,217 shares. The purchase is more than 20 times larger than its prior $125K buy in July and includes a 10,000-share correction of an erroneous sale. The buying comes just days after Sol-Gel reported Q2 results and confirmed its Phase 3 SGT-610 trial remains on track for top-line data in late November.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SLGL was trading at $69.07 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $226.2M. The 52-week trading range was $21.10 to $97.97. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.